SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

18.75p
   
  • Change Today:
    -0.13p
  • 52 Week High: 26.10
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 234.07m
  • Volume: 285,902
  • Market Cap: £43.89m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Executive Director: Simon Hewitson
Group Finance Director: Emily Bertram
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 18.75p
Change Today -0.13p
% Change -0.66 %
52 Week High 26.10
52 Week Low 8.50
Volume 285,902
Shares Issued 234.07m
Market Cap £43.89m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.27% below the market average71.27% below the market average71.27% below the market average71.27% below the market average71.27% below the market average
82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average82.98% below the sector average
Price Trend
80.82% above the market average80.82% above the market average80.82% above the market average80.82% above the market average80.82% above the market average
91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average91.49% above the sector average
Income Not Available
Growth
47.23% above the market average47.23% above the market average47.23% above the market average47.23% above the market average47.23% above the market average
67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average67.74% above the sector average

SBTX Dividends

No dividends found

Trades for 23-May-2025

Time Volume / Share Price
12:39 1,957 @ 18.92p
11:53 20,308 @ 19.00p
11:38 13,541 @ 18.90p
11:33 10,000 @ 19.00p
11:04 6,000 @ 19.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page